The analyst day presentation reinforces Pasqal's commercial traction and technology roadmap but contains no material changes to deal terms. The key catalyst to watch is the shareholder vote on the de-SPAC and the redemption rate — high redemptions would reduce the ~$645M expected cash balance. Monitor for the F-4 effectiveness and proxy mailing date.
Price Chart
Executive Summary
Bleichroeder Acquisition Corp. II (BBCQ) filed a 425 communication on June 30, 2026, furnishing an investor presentation from Pasqal's analyst day. The presentation highlights Pasqal's commercial quantum computing traction, including €16.5M in 2025 commercial revenue, 10 QPUs (7 installed, 3 in production), and a $2.0B pre-money valuation for the de-SPAC with Bleichroeder. The deal is progressing with a $250M committed convertible financing and ~$645M expected cash to the balance sheet, though the presentation is promotional and contains no material changes to deal terms.
Key Financial Metrics
Key Facts
- Pasqal reported €16.5M in 2025 commercial revenue, up from €3.5M in 2024.
- Pasqal has 10 commercial QPUs (7 installed, 3 in production) and €66M+ in booked/awarded business including grants as of March 2026.
- The de-SPAC transaction values Pasqal at ~$2.0B pre-money, with ~$645.2M expected cash to balance sheet assuming no redemptions.
- A $250M committed convertible financing is in place, contributing to $550M+ total capital raised to date.
- Pasqal demonstrated quantum advantage in materials science (TmMgGaO4 simulation) in Q1 2026.
- The presentation is promotional and contains no material changes to deal terms from the prior 8-K filed June 25, 2026.
- The prior 8-K (June 25) amended the board composition to 9 directors (5 French/European) and removed a 1% CEO/chairman LTIP award provision.
Financial Impact
Pasqal reported €16.5M in 2025 commercial revenue (up from €3.5M in 2024), with €66M+ in booked/awarded business. The de-SPAC values Pasqal at ~$2.0B pre-money and is expected to provide ~$645.2M cash to the balance sheet assuming no redemptions, including $250M committed convertible financing.
Risk Factors
- SPAC shareholder redemptions could significantly reduce the ~$645M expected cash to balance sheet.
- The quantum computing industry is early-stage and Pasqal's technology roadmap may face delays or fail to achieve commercialization.
- French foreign investment regulations could impose restrictions or delays on the transaction.
- The combined company will face increased costs and regulatory burdens as a public company.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 425 Filing (Primary) | 0001213900-26-073692 |
| Document: ea0296421-8k425_bleichro2.htm | 0001213900-26-073692 |
| Document: 0001213900-26-073692-index-headers.html | 0001213900-26-073692 |
| Document: 0001213900-26-073692-index.html | 0001213900-26-073692 |
| Document: 0001213900-26-073692.txt | 0001213900-26-073692 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 8, 2026 6w ago | 15-12G | — | awaiting T+20 | — | — |
Aug 20, 2026 9w ago | 425 / 8-K | $10.18 | awaiting T+20 | — | — |
Jun 30, 2026 16w ago | 425 | $10.39 $10.21 | ▼ −1.73% | ▲ +0.45% | — |
Jun 30, 2026 16w ago | 8-K | $10.39 $10.21 | ▼ −1.73% | ▲ +0.45% | — |
Mar 5, 2026 33w ago | 8-K | $10.06 $10.01 | ▼ −0.50% | ▲ +3.29% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers